Europe — EMA

Pamipro (Pamidronate Disodium)

Pamidronate Disodium, the active ingredient in Pamipro, is a bisphosphonate presented as a sterile powder for intravenous infusion use.

Pamidronate Disodium

Request sourcing

Pack/s

What is Pamidronate Disodium?

Pamidronate Disodium, the active ingredient in Pamipro, is a bisphosphonate presented as a sterile powder for intravenous infusion use. It treats elevated bone resorption conditions such as hypercalcemia of malignancy, Paget's disease of bone, and bone metastases in adult patients.

GNH USA supplies Pamipro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

What is Pamidronate Disodium used for?

Pamipro is a bisphosphonate that acts on disorders of bone turnover. - Hypercalcemia of malignancy: helps acquire ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... - Paget's disease of bone: reduces ... ... ... ... .... - Bone metastases from solid tumours: stabilises ... - Osteoporosis ... - Multiple ....

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →